Cronograma de promoção Sarepta Therapeutics, Inc.
Agenda avançada
Gráfico simples
Sobre a empresa Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc., биофармацевтическая компания, работающая на коммерческой стадии, занимается открытием и разработкой терапевтических средств, нацеленных на РНК, генной терапией и другими генетическими терапевтическими методами для лечения редких заболеваний. Компания предлагает инъекцию EXONDYS 51 для лечения мышечной дистрофии Дюшенна (МДД) пациентам с подтвержденной мутацией гена МДД, поддающейся пропуску экзона 51; и VYONDYS 53 для лечения МДД у пациентов с подтвержденной мутацией гена МДД, поддающейся пропуску экзона 53. mais detalhesIPO date | 1997-06-03 |
---|---|
ISIN | US8036071004 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | http://www.sarepta.com |
Цена ао | 124.79 |
Alteração de preço por dia: | -2.25% (119.14) |
---|---|
Alteração de preço por semana: | -1.31% (118) |
Alteração de preço por mês: | -4.46% (121.9) |
Alteração de preço em 3 meses: | -11.19% (131.14) |
Mudança de preço em seis meses: | -18.58% (143.04) |
Mudança de preço por ano: | -1.91% (118.73) |
Mudança de preço em 3 anos: | +54.99% (75.14) |
Mudança de preço em 5 anos: | -13.6% (134.79) |
Mudança de preço em 10 anos: | +255.6% (32.75) |
Mudança de preço desde o início do ano: | -4.46% (121.9) |
|
Subestimação
|
Eficiência
|
|||||||||||||||||||||||||||||||||||||
Dividendos
|
Obrigação
|
Impulso de crescimento
|
Data da transação | Data de divulgação | Insider | Tipo | Preço | Volume | Quantidade | Compartilhe até, % | Compartilhe depois, % | Documento |
---|---|---|---|---|---|---|---|---|---|
29.01.2025 | 31.01.2025 | Estepan Ian Michael Chief Financial Officer |
Comprar | 12 | 189 600 | 15800 | 0 | 0.02 | link |
30.08.2024 | 03.09.2024 | Estepan Ian Michael Chief Financial Officer |
Oferta | 137.36 | 822 100 | 5985 | 0 | -0.01 | link |
03.07.2024 | 08.07.2024 | BEHRENS M KATHLEEN Director |
Comprar | 13.9 | 208 500 | 15000 | 0 | 0.02 | link |
25.06.2024 | 25.06.2024 | Arif Bilal Chief Tech Ops Officer |
Oferta | 163.23 | 636 271 | 3898 | 0 | 0 | link |
25.06.2024 | 25.06.2024 | Brown Ryan Edward EVP, General Counsel |
Oferta | 161.61 | 6 295 840 | 38957 | 0 | -0.04 | link |
25.06.2024 | 25.06.2024 | Brown Ryan Edward EVP, General Counsel |
Comprar | 62.77 | 1 475 100 | 23500 | 0 | 0.03 | link |
24.06.2024 | 25.06.2024 | Arif Bilal Chief Tech Ops Officer |
Oferta | 163.08 | 1 281 650 | 7859 | 0 | -0.01 | link |
02.05.2024 | 06.05.2024 | Murray Dallan Chief Customer Officer |
Oferta | 140 | 508 900 | 3635 | 0 | 0 | link |
05.03.2024 | 06.03.2024 | Mayo Stephen Director |
Oferta | 122.96 | 385 480 | 3135 | 0 | 0 | link |
01.03.2024 | 05.03.2024 | Brown Ryan Edward EVP, General Counsel |
Oferta | 125.34 | 250 680 | 2000 | 0 | 0 | link |
01.03.2024 | 05.03.2024 | Estepan Ian Michael Chief Financial Officer |
Oferta | 128.3 | 153 960 | 1200 | 0 | 0 | link |
01.03.2024 | 05.03.2024 | Arif Bilal Chief Tech Ops Officer |
Oferta | 128.84 | 257 680 | 2000 | 0 | 0 | link |
17.11.2021 | 17.11.2021 | INGRAM DOUGLAS S President & CEO |
Comprar | 79.94 | 2 000 580 | 25026 | 0 | 0.03 | link |
Instituições | Volume | Compartilhar, % |
---|---|---|
Vanguard Group Inc | 8816124 | 9.39 |
Blackrock Inc. | 6211792 | 6.62 |
Janus Henderson Group PLC | 5345785 | 5.69 |
Capital International Investors | 4741485 | 5.05 |
Avoro Capital Advisors LLC | 4344444 | 4.63 |
Wellington Management Group, LLP | 4127610 | 4.4 |
State Street Corporation | 2399078 | 2.55 |
Bank Of New York Mellon Corporation | 2329556 | 2.48 |
T. Rowe Price Investment Management, Inc. | 1919742 | 2.04 |
FMR, LLC | 1507064 | 1.6 |
Supervisor | Cargo | Pagamento | Ano de nascimento |
---|---|---|---|
Mr. Ian Michael Estepan | Executive VP & CFO | 917.53k | 1976 (49 anos) |
Dr. Louise R. Rodino-Klapac Ph.D. | Executive VP, Chief Scientific Officer and Head of Research & Development | 1.04M | 1978 (47 anos) |
Ms. Alison Nasisi | Executive VP & Chief People Officer | N/A | |
Mr. Douglas S. Ingram Esq. | President, CEO & Director | 1.62M | 1963 (62 ano) |
Mr. Dallan Murray | Executive VP & Chief Customer Officer | N/A | |
Mr. Ryan E. Brown J.D. | Executive VP, Chief General Counsel & Corporate Secretary | 823.36k | 1978 (47 anos) |
Mr. Bilal Arif | Executive VP & Chief Technical Operations Officer | N/A | 1972 (53 ano) |
Dr. Diane L. Berry Ph.D. | Executive VP and Chief of Global Policy & Advocacy Officer | N/A | |
Mr. Will Tilton | Senior VP, Head of Strategy & Chief of Staff | N/A | |
Ms. Francesca T. Nolan | Executive Director of Investor Relations and Corporate Communications | N/A |
Endereço: United States, Cambridge, MA , 215 First Street - abrir no Google Maps, abrir mapas Yandex
Site: http://www.sarepta.com
Site: http://www.sarepta.com